FCGR2B and systemic lupus erythematosus: The loss-of-function FcγRIIb-T232 has been linked to susceptibility and/or severity of several auto-immune diseases, particularly SLE (43–45), and also in rheumatoid arthritis (RA) (46) and ITP (47).